MES 1007
Alternative Names: C3 - Mesentech; MES-1007Latest Information Update: 02 Dec 2020
At a glance
- Originator Simon Fraser University
- Developer Mesentech
- Class Benzamides; Carboxylic acids; Drug conjugates; Fluorinated hydrocarbons; Phosphorus compounds; Prostaglandins; Pyrrolidinones; Small molecules
- Mechanism of Action Prostaglandin E EP4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bone disorders; Osteogenesis imperfecta